video

sound

Persian Version

View:

40,272

Download:

22,151

Cites:

Information Journal Paper

Title

FUTURE CHALLENGES AND OPPORTUNITIES IN ONLINE PRESCRIPTION DRUG PROMOTION RESEARCH; COMMENT ON “TROUBLE SPOTS IN ONLINE DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION: A CONTENT ANALYSIS OF FDA WARNING LETTERS”; COMMENTARY

Pages

  211-213

Keywords

DIRECT-TO-CONSUMER (DTC) ADVERTISING 

Abstract

 Despite increased availability of online promotional tools for PRESCRIPTION DRUG marketers, evidence on online PRESCRIPTION DRUG promotion is far from settled or conclusive. We highlight ways in which online PRESCRIPTION DRUG promotion is similar to conventional broadcast and print advertising and ways in which it differs. We also highlight five key areas for future research: branded drug website influence on consumer knowledge and behavior, interactive features on branded drug websites, mobile viewing of branded websites and mobile advertisements, online promotion and non-US audiences, and SOCIAL MEDIA and medication decisions.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    SOUTHWELL, BRIAN G., & RUPERT, DOUGLAS J.. (2016). FUTURE CHALLENGES AND OPPORTUNITIES IN ONLINE PRESCRIPTION DRUG PROMOTION RESEARCH; COMMENT ON “TROUBLE SPOTS IN ONLINE DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION: A CONTENT ANALYSIS OF FDA WARNING LETTERS”; COMMENTARY. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 5(3), 211-213. SID. https://sid.ir/paper/338260/en

    Vancouver: Copy

    SOUTHWELL BRIAN G., RUPERT DOUGLAS J.. FUTURE CHALLENGES AND OPPORTUNITIES IN ONLINE PRESCRIPTION DRUG PROMOTION RESEARCH; COMMENT ON “TROUBLE SPOTS IN ONLINE DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION: A CONTENT ANALYSIS OF FDA WARNING LETTERS”; COMMENTARY. INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT[Internet]. 2016;5(3):211-213. Available from: https://sid.ir/paper/338260/en

    IEEE: Copy

    BRIAN G. SOUTHWELL, and DOUGLAS J. RUPERT, “FUTURE CHALLENGES AND OPPORTUNITIES IN ONLINE PRESCRIPTION DRUG PROMOTION RESEARCH; COMMENT ON “TROUBLE SPOTS IN ONLINE DIRECT-TO-CONSUMER PRESCRIPTION DRUG PROMOTION: A CONTENT ANALYSIS OF FDA WARNING LETTERS”; COMMENTARY,” INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, vol. 5, no. 3, pp. 211–213, 2016, [Online]. Available: https://sid.ir/paper/338260/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops